+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Compliance in two medical centers with criteria for use of caspofungin and lipid-based amphotericin B



Compliance in two medical centers with criteria for use of caspofungin and lipid-based amphotericin B



American Journal of Health-System Pharmacy 61(9): 915-920



Purpose. Patterns of use and compliance with guidelines for use of lipid-based amphotericin B (LBA) and caspofungin at two medical institutions were studied. Methods. Charts of all adult patients receiving LBA or caspofungin or both in combination at the University of California at San Francisco Medical Center (UCSF) and the University of California at San Diego Medical Center (UCSD) between January 1 and October 22, 2001, were reviewed. Results.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 004084468

Download citation: RISBibTeXText

PMID: 15156967

DOI: 10.1093/ajhp/61.9.915


Related references

Susceptibility testing of Candida albicans isolated from oropharyngeal mucosa of HIV(+) patients to fluconazole, amphotericin B and Caspofungin. killing kinetics of caspofungin and amphotericin B against fluconazole resistant and susceptible isolates. Brazilian Journal of Microbiology 40(1): 163-169, 2009

Combination therapy with caspofungin and amphotericin B lipid complex. American Journal of Health-System Pharmacy 59(1): 80-81, 2002

Application of appropriate use criteria for stress myocardial perfusion imaging at two academic medical centers: compliance and association with image findings. Journal of the American Academy of Nurse Practitioners 24(4): 200-208, 2012

Lessons from a case of oromandibular mucormycosis treated with surgery and a combination of amphotericin B lipid formulation plus caspofungin. Acta Haematologica 124(2): 98, 2010

Efficacy and feasibility of aerosolized amphotericin B lipid complex therapy in caspofungin breakthrough pulmonary zygomycosis. Bone Marrow Transplantation 34(5): 467-468, 2004

Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice. Antimicrobial Agents and ChemoTherapy 49(2): 830-832, 2005

In vitro susceptibility of clinical isolates of Aspergillus fumigatus to conventional and lipid formulations of amphotericin B in 2-drug combination with caspofungin and micafungin. International Journal of Infectious Diseases 6(Suppl. 2): 2S45-2S46, 2002

Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet) in combination with caspofungin in experimental systemic aspergillosis. Journal of Pharmaceutical Sciences 93(6): 1382-1389, 2004

Efficacy of amphotericin B or amphotericin B-intralipid in combination with caspofungin against experimental aspergillosis. Journal of Infection 53(2): 131-139, 2006

Therapeutic efficacy of caspofungin alone and in combination with deoxycholate amphotericin B or liposomal amphotericin B for coccidioidomycosis in a mouse model. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 43: 445, 2003

Multicenter, noncomparative study to evaluate safety and efficacy of caspofungin in adults with invasive aspergillosis refractory or intolerant to amphotericin B , AMB lipid formulations , or azoles. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 40: 371, 2000

Therapeutic efficacy of amphotericin b lipid complex , amphotericin b colloidal dispersion , liposomal amphotericin b , and conventional amphotericin b in murine coccicioidomycosis. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 42: 372, 2002

Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin. Leukemia 22(3): 496-503, 2007

In vitro studies on the activity of amphotericin B and lipid-based amphotericin B formulations against Aspergillus conidia and hyphae. Mycoses 45(5-6): 166-169, 2002

Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease. Bone Marrow Transplantation 33(10): 1065-1066, 2004